Cisplatin resistance and mechanism in a viral test system: SV40 isolates that resist inhibition by the antitumor drug have lost regulatory DNA.
Isolates of SV40 that have enhanced ability to survive inhibition by the antitumor drug cisplatin were selected by serial drug challenge in vivo. These mutant viruses have acquired specific deletions within the repeated regulatory motif (GGGCGG)6 or GC box. This DNA element was shown previously to be a strong target of drug attack by cisplatin and other anticancer drugs in vitro and is an important viral and cellular DNA control sequence. Thus, drug resistance in this viral test system is dependent on the loss of important target DNA sequences. The results also indicate that drug efficacy may be related to the ability of certain anticancer drugs to attack regulatory DNA sequences containing strings of guanosines.
Buchanan
R L
RL
Department of Chemistry and Biochemistry, University of California, Los Angeles 90024.
Gralla
J D
JD
D000818:Animals; D001483:Base Sequence; D002460:Cell Line; D002945:Cisplatin / Q000494:pharmacology*; D004279:DNA, Viral / Q000096:biosynthesis / Q000235:genetics*; D004352:Drug Resistance, Microbial / Q000235:genetics; D005809:Genes, Regulator; D005814:Genes, Viral; D007700:Kinetics; D008969:Molecular Sequence Data; D015183:Restriction Mapping; D013539:Simian virus 40 / Q000187:drug effects / Q000235:genetics* / Q000254:growth & development
D004279:DNA, Viral; D002945:Cisplatin